Učitavanje...

Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists

[Image: see text] We recently reported the discovery of a potent GPR40 full agonist AM-1638 (1). Herein, we describe our efforts in improving the drug-like properties of the full agonists through the systematic introduction of polar groups in the C-, D-, and A-rings. This led to the discovery of new...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Du, Xiaohui, Dransfield, Paul J., Lin, Daniel C.-H., Wong, Simon, Wang, Yingcai, Wang, Zhongyu, Kohn, Todd, Yu, Ming, Brown, Sean P., Vimolratana, Marc, Zhu, Liusheng, Li, An-Rong, Su, Yongli, Jiao, Xianyun, Liu, Jiwen (Jim), Swaminath, Gayathri, Tran, Thanhvien, Luo, Jian, Zhuang, Run, Zhang, Jane, Guo, Qi, Li, Frank, Connors, Richard, Medina, Julio C., Houze, Jonathan B.
Format: Artigo
Jezik:Inglês
Izdano: American Chemical Society 2014
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027632/
https://ncbi.nlm.nih.gov/pubmed/24900845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml4005123
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!